EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
February 29, 2024 07:00 ET
|
EDAP TMS S.A.
Record full-year 2023 preliminary unaudited revenue of EUR 60.4 million ($65.4 million USD), an increase of 9.6% over full-year 2022, driven by 31.7% HIFU growth Record Q4 2023 preliminary unaudited...
NBME Acquires MedVR Education to Enhance Assessment for Medical Professionals
February 15, 2024 10:17 ET
|
NBME
PHILADELPHIA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- NBME, a leading medical assessment organization, announces the successful asset acquisition of MedVR Education, an extended reality (XR) platform for...
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
February 01, 2024 08:00 ET
|
EDAP TMS S.A.
60 Patients Completed Enrollment in Under 9 Months Study Results Expected in the Second Half of 2024 LYON, France, February 1, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic...
EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements
January 08, 2024 08:00 ET
|
EDAP TMS S.A.
Company reports preliminary placement results of twelve Focal One Systems, inclusive of ten capital sales LYON, France, January 8, 2024 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in...
EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer
January 02, 2024 08:00 ET
|
EDAP TMS S.A.
LYON, France, January 2, 2024 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that the Company has appointed Ken Mobeck as its Chief...
EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer
December 12, 2023 08:00 ET
|
EDAP TMS S.A.
Represents Key Milestone Toward Universal Coverage for Focal One HIFU in France LYON, France, December 12, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based...
EDAP Appoints Lance Willsey, M.S., M.D. to Board of Directors
December 06, 2023 16:30 ET
|
EDAP TMS S.A.
LYON, France, December 6, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Lance Willsey, M.S.,...
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
December 04, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science industry to its Board of Directors....
EDAP Receives 2023 Industry Category Award from the French National Institute for Intellectual Property (INPI) for Its Therapeutic Ultrasound Technology
November 30, 2023 08:00 ET
|
EDAP TMS S.A.
LYON, France, November 30, 2023 - EDAP TMS SA (Nasdaq: EDAP), (“EDAP”), the global leader in robotic energy-based therapies, today announced that is has received the Industry Category Award from the...
EDAP to Present at Piper Sandler’s 35th Annual Healthcare Conference
November 20, 2023 08:00 ET
|
EDAP TMS S.A.
LYON, France, November 20, 2023 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is...